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Abstract — Aims: To determine the economic burden pertaining to alcohol dependence in Europe. Methods: Database searching
was combined with grey literature searching to identify costs and resource use in Europe relating to alcohol dependence as defined
by the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) or the World Health Organisation’s International
Classification of Diseases (ICD-10). Searches combined MeSH headings for both economic terms and terms pertaining to alcohol
dependence. Relevant outcomes included direct healthcare costs and indirect societal costs. Main resource use outcomes included
hospitalization and drug costs. Results: Compared with the number of studies of the burden of alcohol use disorders in general, rela-
tively few focussed specifically on alcohol dependence. Twenty-two studies of variable quality were eligible for inclusion. The direct
costs of alcohol dependence in Europe were substantial, the treatment costs for a single alcohol-dependent patient lying within the
range €1591–€7702 per hospitalization and the annual total direct costs accounting for 0.04–0.31% of an individual country’s gross
domestic product (GDP). These costs were driven primarily by hospitalization; in contrast, the annual drug costs for alcohol depend-
ence were low. The indirect costs were more substantial than the direct costs, accounting for up to 0.64% of GDP per country annual-
ly. Alcohol dependence may be more costly in terms of health costs per patient than alcohol abuse. Conclusions: This review
confirms that alcohol dependence represents a significant burden for European healthcare systems and society. Difficulties in compar-
ing across cost-of-illness studies in this disease area, however, prevent specific estimation of the economic burden.
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INTRODUCTION
Several attempts have previously been made to estimate the
burden of alcohol use and alcohol use disorders overall, both
in Europe and globally (Andlin-Sobocki et al., 2005;
Anderson and Baumberg, 2006; Rehm et al., 2009; Rehm
et al., 2010; Gustavsson, 2011; Olesen et al., 2012).
However, many of these studies do not report on the eco-
nomic burden associated with alcohol dependence specifical-
ly. Although alcohol dependence is a clinical condition
associated with substantial disability and loss of quality of
life (Saarni et al., 2007; Saatcioglu et al., 2008;
Samokhvalov et al., 2010), the tangible and intangible costs
associated with this particular sub-category of alcohol
misuse in Europe are unclear. It has been suggested that a
substantial 61% of the costs associated with alcohol use can
be attributed to alcohol dependence or heavy drinking
(Mohapatra et al., 2010). However, no previous literature
review to assess the cost-of-illness studies of alcohol depend-
ence has been performed. While treatments exist for alcohol
dependence, the scale of the economic benefits that could
potentially be gained from its effective prevention and treat-
ment, therefore, also remains uncertain.
The terminology surrounding alcohol dependence, alcohol
abuse and alcohol misuse is often unclear. Alcohol misuse
is generally considered an umbrella term for both ‘alcohol
dependence’ and ‘alcohol abuse’. Two main classification
systems are commonly used to differentiate alcohol depend-
ence from alcohol abuse: the Diagnostic and Statistical
Manual of Mental Disorders (DSM-IV) and the World
Health Organization’s International Classification of Diseases
(ICD-10). Concordance between the two classification
systems is high (Saunders, 2006). Under both systems, a
diagnosis of alcohol dependence demands that three or more
of a set of criteria were met within the previous year; these
criteria include tolerance, withdrawal, persistent consumption
despite harmful consequences and a loss of interest in alterna-
tive activities or former interests.
In 2010, the European Medicines Agency stated that the
main goals of treatment for alcohol dependence are to
achieve abstinence, reduce the frequency and severity of
relapse and improve health and psychosocial functioning.
In contrast to the zero-tolerance approach of preventing
relapse, the alternative ‘harm reduction approach’ advocates
a reduction in alcohol consumption, and is now also consid-
ered a valid treatment goal for many alcohol-dependent
patients (European Medicines Agency, 2010). In addition to
psychosocial therapy, a number of adjuvant therapeutic
agents, such as disulfiram, acamprosate and naltrexone, have
been developed over the past few decades to help patients
avoid relapse. Despite the first of these agents being avail-
able since the 1950s, it is thought that the number of patients
benefitting from them is small (European Medicines Agency,
2010) and the prevalence of alcohol dependence as defined
by the DSM-IV and the ICD-10 remains high (European
Medicines Agency, 2005; Wittchen and Jacobi, 2005;
Anderson and Baumberg, 2006).
At global level, estimates of the prevalence of alcohol de-
pendence in Europe are particularly high. A report ordered
by the European Commission and conducted by the Institute
of Alcohol Studies in 2006 found that Europe is the heaviest
drinking region in the world, with an estimated 23 million
Europeans being alcohol dependent every year (Anderson
and Baumberg, 2006). A prevalence rate of 5.2% was
reported for several European countries in 2004 (European
Medicines Agency, 2005), while a range of 0.1–6.6% was
Alcohol and Alcoholism Vol. 48, No. 3, pp. 259–269, 2013 doi: 10.1093/alcalc/agt004
Advance Access Publication 30 January 2013
© The Author 2013. Medical Council on Alcohol and Oxford University Press. All rights reserved
reported in a multi-method analysis of data from various
European countries in 2005 (Wittchen and Jacobi, 2005).
Many studies have reported an association between the
level of drinking, or alcohol consumption in general, and
economic burden (Anderson and Baumberg, 2006). These
estimates include the healthcare costs of alcohol-related
diseases, judicial costs and costs associated with the loss of
productivity from unemployment, absenteeism and premature
retirement or mortality. The Alcohol in Europe report esti-
mated that the tangible costs of alcohol in 2003 amounted
to €125 billion, equivalent to 1.3% of European gross do-
mestic product (GDP) (Anderson and Baumberg, 2006). The
intangible costs of alcohol (pertaining to the value placed on
pain, suffering and loss of life) amounted to €270 billion.
However, the burden relating specifically to the medical con-
dition of alcohol dependence, which could be reduced with
effective treatment, is considerably more unclear.
This literature review aimed primarily to ascertain the
economic burden of alcohol dependence in Europe. The sec-
ondary aim, dependent on the availability of data, was to
investigate the changing burden of alcohol dependence in
Europe over time and to assess the difficulties of comparing
cost-of-illness studies in this area.
MATERIALS AND METHODS
Database review
A database review was performed to identify publications
reporting the economic burden of alcohol dependence.
Alcohol dependence was defined according to the criteria spe-
cified by either the DSM-IV or the ICD-10. PubMed (includ-
ing MEDLINE and MEDLINE In-Process), Journals@Ovid
and the Cochrane Library were searched in October 2011.
Searches combined MeSH headings for both economic terms
and terms pertaining to alcohol dependence, as well as rele-
vant text word searches. The economic terms included ‘costs
and cost analysis[MeSH]’, ‘cost[tw]’, ‘econom*[tw]’ and
‘burden[tw]’.
Libraries from each database were merged and
de-duplicated, abstracts were screened for inclusion by a single
assessor and extracted results were confirmed by a second re-
viewer. To be included, articles had to present cost or resource
use data for alcohol-dependent patients in the European Union.
Alcohol dependence was considered to encompass terms such
as alcoholism, alcohol withdrawal and alcohol addiction. There
were no limits on the study type or length of study follow-up,
and outcomes for alcohol-dependent populations could be com-
pared with no population or any other population, including
alcohol abusers. Finally, the articles had to be in English or any
European language.
Full texts were obtained for articles deemed eligible based
on information presented in their abstracts. Full texts were
subjected to identical screening criteria, with an additional
exclusion category for articles not presenting costs for
alcohol dependence separately to costs for alcohol abuse or
misuse.
Grey literature searching
In addition to the database review, grey literature searching
of publically available material from public health bodies
was performed. These searches were conducted in Google
with search terms similar to those used in the literature
review, comprising both an economic and an alcohol de-
pendence component. The data sources identified were sub-
jected to the same screening criteria as the articles identified
in the literature review, with the same inclusion and exclu-
sion criteria.
Extraction of results
The relevant outcomes that were extracted included direct
healthcare costs and indirect societal costs, including carer
costs and those associated with the judicial system (legal and
prison costs). Data on resource utilization in terms of health-
care resources, such as hospitalization, were also collected.
The major summary measures were anticipated to be mean
cost per alcohol-dependent patient and total cost of alcohol
dependence on a national or international level.
To enable direct comparison of costs across years and
currencies, all the costs were converted into Euros 2012.
Costs from Eurozone countries that were published before
the introduction of the Euro were inflated to 2002 using
Eurostat and inflation.eu, converted into Euros using the
average exchange rate in 2002 on OANDA and then inflated
to 2012. Costs published in Euros were simply inflated to
2012 values. Costs in British pounds were inflated to 2012
and converted into Euros (using the exchange rate on 23
March 2012). All the costs were then adjusted for purchasing
power parity (PPP) using the 2010 PPP rates from Eurostat
(2012). These costs were also presented as a proportion of
either total GDP (for costs on a national level) or GDP per
inhabitant (for costs per patient), using data from Eurostat
(2012). Costs on a national level presented as a proportion of
total GDP were also presented as a proportion of GDP spent
on healthcare, using data from the Organisation for
Economic Co-operation and Development (OECD/European
Union, 2010).
RESULTS
The combined searches for the database review resulted in
4123 unique records for screening. A total of 4027 of these
records were excluded (rationales are presented in Fig. 1)
and 95 records included at the abstract review stage. Of the
95 abstracts eligible for inclusion, full texts for 25 were not
obtainable and 59 records were excluded following full-text
review. In total, 11 full texts (pertaining to ten different
studies) were deemed eligible for extraction.
Of the 59 articles excluded following full-text review,
23 reported economic or resource utilization outcomes for
alcohol-dependent patients combined with outcomes for
alcohol abuse; nine did not report any outcomes pertaining
to alcohol dependence; 18 presented outcomes pertaining to
alcohol dependence that were not relevant to the scope of
this review; and eight reported economic or resource utiliza-
tion data pertaining to alcohol dependence, but in
non-European patients. In addition, one article was found to
be a duplicate.
An additional 26 studies identified through grey litera-
ture searching were screened for inclusion, and 11 full
texts were eligible for extraction. In total, therefore, 4148
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records were captured through both the database searching
and grey literature searching and ultimately 22 records
were extracted (Fig. 1). Of these, 11 included records
sourced from the database review and 11 from the grey
literature searching.
The majority of articles identified presented one of two
types of outcome: cost or resource use per alcohol-dependent
patient or total economic burden/resource utilization at na-
tional level (Table 1). Three studies were prospective, one
was a review, one was a factsheet, one presented a brief
summary of symposium proceedings, one entailed a survey,
four entailed retrospective medical chart reviews and 10
entailed the retrospective collation of national statistics.
However, the relative quality of many of the studies was dif-
ficult to assess due to the poor reporting of the methodolo-
gies and cost sources used.
Table 2 presents extracted data on healthcare cost per
patient from the seven studies reporting this outcome. The
studies are varied, being conducted in France, Germany,
Switzerland and the UK and presenting costs from 1964 to
2007. With the exception of the daily costs of treatment
reported in a French study in 1964 (Lereboullet, 1968), all
treatment costs for a single patient lie within the range of
5.3–15.0% of GDP per inhabitant (Niquille et al., 1991;
McKenna et al., 1996; Nalpas et al., 2003; Salize et al.,
2004; Parrott et al., 2006; Stamm et al., 2007). However,
despite the cost conversion into Euros 2012 performed, the
reported outcomes are different enough to restrict direct com-
parison of costs. For example, reported healthcare cost per
patient may encompass hospitalization cost per day, total
cost of a single hospitalization or total hospitalization costs
over the course of a year.
Resource utilization by alcohol-dependent patients with
regard to length of hospital stay is presented in Table 3. Five
studies reported this outcome. While three studies present
comparable measures, such as length of stay per hospitaliza-
tion per patient in days (Lereboullet, 1968; Niquille et al.,
1991; Nalpas et al., 2003), one study presents the total
annual number of hospital days consumed by alcohol-
dependent patients (Kopp and Fenoglio, 2000) and another
presents only the proportion of alcohol-dependent patients in
a 6-month period with length of hospital stay less than and
>24 h (Baune et al., 2005). Of the three studies presenting
comparable outcomes, the oldest study is an outlier, report-
ing a mean length of stay per hospitalization per patient of
55 days (Lereboullet, 1968). The other two studies indicate a
range of 11–28 days per hospitalization per patient (Niquille
et al., 1991; Nalpas et al., 2003). One reason for the differ-
ence in length of stay estimations may be that one study con-
sidered length of stay in rehabilitation centres (Nalpas et al.,
2003), while another considered hospitalization in general
hospital wards (Niquille et al., 1991).
Further to the data collated on length of hospital stay, a
fact sheet from the Institute of Alcohol Studies (2009) pre-
sented the number of UK NHS admissions with a primary
diagnosis of disease specifically related to alcohol for every
year between 1995/1996 and 2006/2007. Summing the
number of admissions specifically for ‘dependence syn-
drome’, ‘withdrawal state’ and ‘withdrawal state with delir-
ium’, the number of admissions increased from 16,894 in
1995/1996 to 20,886 in 2006/2007.
Table 4 presents the cost of drugs for alcohol dependency.
Three studies report cost per patient, ranging from €86.61
to €557.89, and 0.3 to 1.8% of GDP per inhabitant
Fig. 1. Flow of papers through the literature review
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Table 1. Summary of the included studies
Reports cost/resource use per patient
Reports total economic burden/resource
utilization
Reports other
outcomes
Study Country/region Source type
Number of
alcohol-
dependent
patients/survey
respondents
Number/
cost of
healthcare
contacts
Length/
cost of
hospital
stay
Drug
use/
costs
Treatment
use/cost
Diagnostic
tests/cost Other
Number/
length/
cost of
hospital stays
Cost of drugs
prescribed
for alcohol
dependency Other
Number of
patients with
hospital stays
≥24 h or <24 h
Database searching
Baune et al. (2005) Germany Prospective, cross-sectional study of 11
emergency rooms in 11 hospitals
1224 X
Brecht et al. (1996) Germany Retrospective collation of national statistics N.A. X
Lereboullet (1968) France Retrospective medical record review of
hospitals in le department de la Seine
260 X X
McKenna et al. (1996) UK Retrospective review of patients who had been
treated at an Alcohol Problems Clinic
180 X X X
Nalpas et al. (2003) France Retrospective database review of patients
attending any of four specialized
alcoholism treatment centres
267 X X X X X X
Niquille et al. (1991) Switzerland Prospective, comparative study of alcoholic
and non-alcoholic patients in one hospital
103 X X X X
Reynaud et al. (1999,
2001)
France Retrospective collation of national statistics
using two different methods to estimate
health costs linked to alcoholism
N.A. X
Salize et al. (2004) Germany Symposium proceedings summary N.A. X
Stamm et al. (2007) Germany Retrospective database analysis of health
insurance expenses for alcoholics versus
non-alcoholics
127 X X
Trillat (1980) France Review N.A. X
Grey literature searching
Anderson and Baumberg
(2006)
Europe Report N.A. X
Banz et al. (1993) Germany Report N.A. X
Bergmann and Horch
(2002)
Germany Report presenting aggregated national statistics N.A. X
Cabinet Office Strategy
Unit (2003)
UK Report presenting aggregated national statistics N.A. X X
Department of Health,
Social Services and Public
Safety (2010)
Northern Ireland Report presenting aggregated national statistics N.A. X
Institute of Alcohol
Studies (2009)
England Factsheet/report N.A. X
Jeanrenaud and Pellegrini
(2007)
Switzerland Survey of willingness-to-pay for treatment for
a household member in
non-alcohol-dependent respondents
236 X
Jones et al. (2010) UK (Leeds) Report N.A. X
Kopp and Fenoglio (2000) France Report N.A X X
Parrott et al. (2006) UK Prospective analysis 103
Scottish Government
Social Research (2010)
Scotland Report N.A. X X
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(McKenna et al., 1996; Nalpas et al., 2003; Stamm et al.,
2007). However, as with hospital stay, the outcomes are
not directly comparable between studies, one study present-
ing drug costs per hospitalization (Nalpas et al., 2003),
another drug cost per 6 months (McKenna et al., 1996) and
another drug costs per year (Stamm et al., 2007). Several
studies were also identified that reported the total annual eco-
nomic burden of prescription drugs for alcohol dependency;
these costs ranged from 0.000005% of total GDP for one
city in the UK (Jones et al., 2010) to 0.0002% for England
as a whole (Scottish Government Social Research, 2010).
These costs ranged from 0.00006 to 0.002% of the total
annual GDP spent on healthcare.
The total annual direct national costs of alcohol depend-
ence are presented in Table 5. These costs are expected to be
the most comparable outcome across studies, although in
some cases the methodological quality of the studies is diffi-
cult to assess as the methodology is not reported in detail.
The estimates ranged from 0.041% of GDP in 1996 (Brecht
et al., 1996) to 0.314% in 2002 (Bergmann and Horch,
2002), both estimates being from Germany. In terms of
annual GDP spent on healthcare, these costs amounted to
0.39% (Brecht et al., 1996) and 2.99% (Bergmann and
Horch, 2002), respectively. Table 6 reports the indirect,
social costs of alcohol dependence in Europe, with estimates
ranging from 0.0009% of annual GDP (a Scottish estimate
of the annual cost of unemployment due to alcohol depend-
ency; Scottish Government Social Research, 2010) to
0.640% (a European-wide estimate of the intangible cost of
alcohol dependence on family members; Anderson and
Baumberg, 2006). The highest estimate (Anderson and
Baumberg, 2006) amounted to 7.72% of annual GDP spent
on healthcare for the European Union as a whole. Indirect
costs on a national level are not directly comparable, as the
studies investigate different social costs and measure them in
different ways.
DISCUSSION
Evidence from this review indicates that the economic
burden of alcohol dependence in Europe is large, the annual
total direct costs at national level ranging from €1 billion to
€7.8 billion in Euros 2012, accounting for 0.04–0.31% of a
country’s annual GDP (Table 5; Banz et al., 1993; Brecht
et al., 1996; Bergmann and Horch, 2002; Salize et al., 2004).
Table 2. Mean cost of healthcare per alcohol-dependent patient. Studies are listed chronologically by year of cost
References Country Year of cost Cost components
Original cost in
source
Up-rated and
PPP-adjusted cost
in Euros 2012 (€)
Up-rated and
PPP-adjusted cost as
a proportion of GDP
per inhabitant (%)
Lereboullet (1968) France 1964/1965 Hospital cost for treating chronic
alcoholics per patient per day
78.82 French
francs
93 0.31
Niquille et al. (1991) Switzerland 1988/1989 Total hospital charges per patient per
hospitalization
11,900 Swiss
francs
7702.36 15.04
McKenna et al. (1996) UK 1992/1993 Total health service cost per patient
over a 6-month period
£1222.06 1907.83 6.96
Salize et al. (2004) Germany 1998 Average hospital cost per alcoholic
AOK enrolee per year
€3008 2890.40 9.54
Nalpas et al. (2003) France 2000 Total cost of hospitalization for
alcohol withdrawal per patient
€1397.50 1591.22 5.34
Stamm et al. (2007) Germany 2000 Total hospital costs per alcoholic
patient per year
€1577.55 1610.44 5.32
Parrott et al. (2006) UK 2003/2004 Total cost of treatment per treatment
episode per patient at two alcohol
detoxification services
Centre 1: £1113 Centre 1: 1857.10 Centre 1: 6.78
Centre 2: £1054 Centre 2: 1758.66 Centre 2: 6.42
Table 3. Length of hospital stay for alcohol dependence. Studies are listed chronologically by the year the data originated from
References Country
Year data
originated from Estimate components Length of stay (days)
Lereboullet (1968) France 1964/1965 Mean length of stay per hospitalization per patient
with chronic alcoholism
55.26
Niquille et al. (1991) Switzerland 1988/1989 Mean length of stay per hospitalization per
alcoholic patient
16
Kopp and Fenoglio
(2000)
France 2000 Total national number of hospital stays in 1993 and
average duration of hospital stay for
alcohol-dependent men and women with
psychological symptoms of alcohol dependence
Men: 68,077 hospital stays in 1993 with an
average length of stay of 9.6 days
Women: 21,841 hospital stays in 1993 with
an average length of stay of 9.5 days
Nalpas et al. (2003) France 2000 Mean length of stay per hospitalization per patient
with alcohol withdrawal
Centre 1: 11
Centre 2: 28
Centre 3: 19
Centre 4: 19
Baune et al. (2005) Germany 2000/2001 Proportion of alcohol-dependent and alcohol
withdrawal patients in a 6-month period with
hospital stays ≥24 h
Alcohol dependence: 68.3%
Alcohol withdrawal: 82.2%
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Table 4. Drug costs for alcohol dependence
Type of cost References Country Year of cost Cost components
Original cost in
source
Up-rated and
PPP-adjusted
cost in Euros
2012 (€)
Up-rated and
PPP-adjusted cost
as a proportion
of GDP per
country (%)
Up-rated and
PPP-adjusted cost
as a proportion of
GDP spent on
healthcare per
country (%)
Up-rated and
PPP-adjusted cost
as a proportion of
GDP per
inhabitant (%)
Per patient McKenna et al. (1996) UK 1992/1993 Mean drug costs per patient over
a 6-month period
£84.72 168.67 – – 0.62
Stamm et al. (2007) Germany 1999/2000 Total drug costs per alcoholic
patient per year
€546.50 557.89 – – 1.84
Nalpas et al. (2003) France 2000 Total drug costs per patient per
hospitalization
€76.07 86.61 – – 0.29
Total economic
burden
Scottish Government
Social Research
(2010)
England 2006/2007 Total annual and national burden
to the NHS of alcohol
dependency-prescribed drugs
£2.1 million 3,279,313 0.0002 0.0022 –
Scotland 2007 Total annual and national burden.
Included drugs are acamprosate
and disulfiram. Separate costs
provided for benzodiazepines
under different assumptions
of prevalence for prescriptions
of benzodiazepines for alcohol
withdrawal (5%, 10% and 25%)
Acamprosate and
disulfiram:
£866,125
1,352,518 0.0001 0.0009 –
Benzodiazepines:
5% £388,313
10% £766,626
25% £1,941,566
606,381
1,197,143
3,031,911
0.00004
0.0001
0.0002
0.00041
0.0008
0.002
–
–
–
Cabinet Office
Strategy Unit (2003)
England 2000/2001 Total annual and national
economic burden of alcohol
dependency-prescribed drugs.
Drugs included were
acamprosate and disulfiram
£1.6 million 2,997,911 0.0002 0.0020 –
Jones et al. (2010) England 2008/2009 Total annual burden of alcohol
dependency-prescribed drugs
in Leeds. Drugs included were
acamprosate and disulfiram
£56,234 82,937.68 0.000005 0.000056 –
Department of Health,
Social Services and
Public Safety (2010)
Northern
Ireland
2008/2009 Total annual burden of alcohol
dependency-prescribed drugs
in Northern Ireland. Drugs
included were acamprosate
and disulfiram
£0.3 million 442,459.82 0.00003 0.0003 –
Within cost type, studies are listed chronologically by year of cost.
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Table 5. Total direct national costs of alcohol dependence. Studies are listed chronologically by year of cost
References
Country/
region
Secondary
references
Year
of
cost Cost components Original cost in source
Up-rated and
PPP-adjusted cost in
Euros 2012 (€)
Up-rated and PPP-adjusted
cost as a proportion of GDP
per country (%)
Up-rated and PPP-adjusted cost
as a proportion of GDP spent on
healthcare per country (%)
Brecht et al.
(1996)
Germany N.A. 1990 Total annual economic cost
(including cost of treatment in
acute hospitals, ambulatory
care and rehabilitation units)
DM 1553 million
(subdivided into acute
hospitals: DM 869 million;
ambulatory care: DM 311
million; and rehabilitation
units: DM 373 million)
1,014,047,666
Acute hospitals:
567,422,680
Ambulatory care:
203,070,717
Rehabilitation units:
243,554,269
0.041
Acute hospitals: 0.023
Ambulatory care: 0.008
Rehabilitation units:
0.010
0.390
Acute hospitals: 0.218
Ambulatory care: 0.078
Rehabilitation units: 0.094
Reynaud
et al. (1999)
France N.A. 1996 Total annual economic cost
of alcoholism based on
two different methods
Method 1: 14 billion francs
(lower estimate) or 16
billion francs (higher
estimate)
Method 1:
2,312,169,347 to
2,900,459,447
Method 1: 0.131–0.150 Method 1: 1.17–1.34
Method 2: 20 billion francs Method 2:
3,625,574,308
Method 2: 0.188 Method 2: 1.68
Reynaud
et al.
(2001)
France N.A. 1996 Total annual economic cost
of alcoholism based on
two different methods
Method 1: $2.3 billion (lower
estimate) or $2.7 billion
(higher estimate)
Method 1:
2,364,978,101 to
2,776,278,640
Method 1: 0.122–0.144 Method 1: 1.09–1.28
Method 2: $3.3 billion Method 2:
3,393,229,449
Method 2: 0.176 Method 2: 1.57
Salize et al.
(2004)
Germany Banz et al.
(1993)
1989 Total annual societal cost €2.7 billion 2,594,445,587 0.105 0.998
Bergmann
and Horch
(2002)
2002 Total annual direct costs of care €8.1 billion 7,783,336,760 0.314 2.99
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Table 6. Total indirect national costs of alcohol dependence. Studies are listed chronologically by year of cost
References
Country/
region
Secondary
references
Year
of
cost Cost components Original cost in source
Up-rated and
PPP-adjusted cost in
Euros 2012 (€)
Up-rated and
PPP-adjusted cost
as a proportion of
GDP per country
(%)
Up-rated and
PPP-adjusted cost as
a proportion of GDP
spent on healthcare
per country (%)
Up-rated and
PPP-adjusted cost
as a proportion of
GDP per
inhabitant (%)
Brecht et al. (1996) Western
Germany
N.A 1990 Total annual indirect costs
of alcoholism (including
the costs attributed to
inability to work, early
retirement and premature
mortality)
DM 4422 million
(subdivided into
inability to work:
DM 1150 million;
early retirement:
DM 988 million;
and premature
mortality: DM 2284
million)
2,887,391,358
(subdivided into
inability to work:
750,904,582; early
retirement:
645,124,980; and
premature mortality:
1,491,361,796)
0.117
Inability to
work: 0.030
Early
retirement:
0.026
Premature
mortality: 0.060
1.110
Inability to
work: 0.289
Early
retirement: 0.248
Premature
mortality: 5.461
–
Salize et al. (2004) Germany Bergmann and
Horch, 2002
2002 Total annual social costs
of alcoholism
€11.8 billion 11,338,688,119 0.458 4.360 –
Anderson and
Baumberg (2006)
Europe N.A. 2003 Total intangible cost of
alcohol dependence on
family members across
1 year
€68 billion 78,490,934,637 0.640 7.716 –
Cabinet Office
Strategy Unit
(2003)
UK N.A. 2001 Total annual cost of
absenteeism among
alcohol-dependent
employees
£1.2 billion 2,083,428,571 0.122 1.404 –
Scottish Government
Social Research
(2010)
Scotland Study by Catalyst/
Scottish
Executive
2001 Total annual cost of
unemployment due
to alcohol dependency
for men and women
£84 million 145,840,179 0.009 0.098 –
Scottish
Government
(application of
method used by
the Cabinet
Office Strategy
Unit)
2001 Total annual cost of
unemployment due
to alcohol dependency
for both men and
women
£146 million 253,483,929 0.015 0.171 –
Update of Catalyst/
Scottish
Executive report
2007 Total annual cost of
unemployment due
to alcohol dependency
for men only
£150.9 million 235,641,964.29 0.014 0.159 –
Update of Scottish
Government’s
2001 analysis
2007 Total annual cost of
unemployment due
to alcohol dependency
for both men and
women
£191.5 million 299,041,964 0.018 0.201 –
Jeanrenaud and
Pellegrini (2007)
Switzerland N.A. 2007 National annual intangible
cost of alcohol
dependence on
household members
CHF 1.6 billion 1,119,758,219.89 0.281 2.648 –
Annual intangible cost
of alcohol dependence
per individual household
member
CHF 5400 3779.18 – – 7.381
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This translates into a range of 0.39–2.99% of annual GDP
spent on healthcare per country. The main cost driver for
direct costs appears to be hospitalization for alcohol-
dependent patients, which can consume as much as 15% of
annual GDP per inhabitant for a single patient (Niquille
et al., 1991), and is in turn likely to be affected by the length
of hospital stay. In contrast, drug costs for alcohol depend-
ency at national level account for a very small proportion of
an individual country’s annual GDP, ranging from
0.000005% (Jones et al., 2010) to 0.0002% annually
(Cabinet Office Strategy Unit, 2003; Scottish Government
Social Research, 2010). As a proportion of GDP spent on
healthcare, these costs remain small, ranging from 0.00006
to 0.002% annually. Estimates for length of stay per hospital-
ization per patient vary widely, with a range of 11–28 days
recorded in four specialized French alcoholism treatment
centres in 2000 (Nalpas et al., 2003). Similar to the findings
in the 2003 Alcohol in Europe report on the cost of alcohol
consumption overall (Anderson and Baumberg, 2006), indirect
costs of alcohol dependence also appear to be substantial,
accounting for up to 0.64% of annual European GDP as a
whole (€68 billion; Table 6; Brecht et al., 1996; Cabinet
Office Strategy Unit, 2003; Anderson and Baumberg, 2006;
Scottish Government Social Research, 2010). These indirect
costs amount to 7.7% of annual GDP spent on healthcare in
the EU. Evidence also suggests that alcohol dependence is
more costly per patient in terms of health costs than alcohol
abuse (€1908 versus €986, respectively, for a 6-month period
after conversion into Euros 2012; McKenna et al., 1996).
It is difficult to draw conclusions on whether the burden
of alcohol dependence has altered over time. Estimates from
two German studies may be suggestive of an increasing
burden, with direct national costs increasing from 0.04% of
GDP in 1990 to 0.31% of GDP in 2002 (Brecht et al., 1996;
Bergmann and Horch, 2002). However, we have insufficient
information to ascertain how similar the cost components
and methodologies used to derive the estimates were in these
two studies. Updates of figures in government reports may
provide a more reliable insight into the changing economic
burden of alcohol dependence over time; it can be seen in
the Scottish Government Social Research, (2010) that the
annual cost of unemployment due to alcohol dependency
increased from €253.5 million in 2001 to €299 million in
2007 (after conversion into Euros 2012). In this report,
attempts were made to use the same methodology in 2007 as
in 2001, making these two cost estimates comparable.
The increasing number of hospital admissions in the UK
NHS for ‘dependence syndrome’, ‘withdrawal state’ and
‘withdrawal state with delirium’ between 1995/1996 and
2006/2007 may also indicate an increasing burden of alcohol
dependence, with all of these diagnoses pertaining to alcohol
dependence as defined by the World Health Organization’s
ICD-10 criteria (Institute of Alcohol Studies, 2009). The pos-
sible increasing burden of alcohol dependence in the UK
may be correlated with an increase in per capita alcohol con-
sumption since the 1960s, in contrast to a declining trend in
many southern European countries such as Italy and Spain
(World Health Organization, 2011).
While the cost and resource utilization estimates captured
in Tables 2–6 confirm that alcohol dependence is associated
with a considerable economic burden, it is clear from the
relatively small number of studies identified that there is a
lack of data specifically available for the alcohol-dependent
population. This is highlighted by the large number of
records excluded from the literature search for the reason that
they reported the economic burden of alcohol abuse, or out-
comes on alcohol-dependent patients combined inseparably
with outcomes for alcohol abuse. Government reports and
other reports at national level generally fail to present costs
for alcohol dependence separately to costs for alcohol abuse,
instead presenting aggregate results for the number of emer-
gency room attendances, inpatient hospitalization and crim-
inal justice system resource use. This means that only certain
costs directly relevant to alcohol-dependent individuals, such
as the cost of prescription drugs for alcohol dependency, can
be extracted. According to one report by the UK Cabinet
Office, analysing data separately for dependent drinkers
would be valuable only if policy were to be formulated spe-
cifically for alcohol-dependent subgroups (Cabinet Office
Strategy Unit, 2003). It seems that the costs of alcohol de-
pendence are regularly overshadowed by the costs of alcohol
abuse overall and are often neglected in research. As the
burden of alcohol dependence is still substantial, however,
and dependence is a manageable condition, there is an
unmet clinical need, which could be alleviated by the target-
ing of valid treatment goals other than relapse prevention,
such as harm reduction.
Comparing cost estimates from different cost-of-illness
studies is notoriously difficult (World Health Organization,
2009). The challenges presented by such cross-study compar-
isons were acknowledged in a summary of symposium pro-
ceedings, which presented annual societal cost of alcohol
dependence estimates in Germany ranging from €2.7 billion
to €11.9 billion (Salize et al., 2004). Possible reasons cited
for the wide variation in estimates included the use of differ-
ent definitions, data sources, cost categories and calculation
methods. Similar problems were identified during this review
and are discussed in further detail below.
Only a limited number of studies considered in this review
defined the alcohol-dependent population in terms of stan-
dardized, internationally recognized instruments such as the
ICD-10, DSM-IV or the Michigan Alcoholism Screening
Test (Niquille et al., 1991; Nalpas et al., 2003). It is, there-
fore, unlikely that the populations included in each study
were fully comparable. While efforts were made to include
only those studies pertaining specifically to alcohol depend-
ence, it is possible that differential and potentially misleading
use of the word ‘alcoholic’ or ‘alcoholism’ in some studies
may have led to the inadvertent inclusion of costs for
patients with alcohol abuse. Also with regard to older
studies, such as Lereboullet (1968), it is known that the def-
inition of alcohol dependence has evolved in recent decades
(Saunders, 2006).
Government reports account for many of the cost sources
identified in the grey literature searching (Kopp and
Fenoglio, 2000; Bergmann and Horch, 2002; Cabinet Office
Strategy Unit, 2003; Institute of Alcohol Studies, 2009;
Department of Health Social Services and Public Safety,
2010; Jones et al., 2010; Scottish Government Social
Research, 2010). These reports tend to use national data sets,
and where costs pertaining to alcohol dependency are pre-
sented, they can be assumed to be relatively robust.
However, when comparing across studies, it was often
unclear whether the cost components were identical and
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whether the costing sources were of equivalent reliability and
accuracy. Some costs were found to be inherently more com-
parable as the number of possible cost components was ne-
cessarily limited; for example, all government estimates for
the cost of prescription drugs for alcohol dependency
included costs for acamprosate and disulfiram only (Cabinet
Office Strategy Unit, 2003; Department of Health Social
Services and Public Safety, 2010; Jones et al., 2010; Scottish
Government Social Research, 2010).
Different cost calculation methods were also used in differ-
ent studies. While some studies were bottom-up analyses
(Lereboullet, 1968; Niquille et al., 1991; McKenna et al.,
1996; Nalpas et al., 2003; Baune et al., 2005; Parrott et al.,
2006), others used varying top-down approaches (Brecht
et al., 1996; Reynaud et al., 1999; Kopp and Fenoglio, 2000;
Reynaud et al., 2001; Bergmann and Horch, 2002; Cabinet
Office Strategy Unit, 2003; Stamm et al., 2007; Department
of Health Social Services and Public Safety, 2010; Jones
et al., 2010; Scottish Government Social Research, 2010).
The consequences of using alternative top-down approaches
are highlighted by Reynaud et al. (1999, 2001), who used
two different methods for estimating healthcare costs linked
to alcoholism in France, obtaining estimates ranging from
$2.3 billion to $3.3 billion annually.
Finally, the large diversity of study types included meant
that developing standardized quality assessment criteria with
which to appraise each one was impractical. Even within
studies of the same type, assessing quality was difficult due
to differences in primary objectives between studies. Many
studies were not designed to capture the economic burden of
alcohol-dependent patients, and in many cases data relevant
to the alcohol-dependent population was presented only inci-
dentally (Kopp and Fenoglio, 2000; Bergmann and Horch,
2002; Cabinet Office Strategy Unit, 2003; Baune et al.,
2005; Anderson and Baumberg, 2006; Department of Health
Social Services and Public Safety, 2010; Scottish
Government Social Research, 2010). While the methodology
of many studies or reports may have been satisfactory to
address their primary objectives, for the purposes of this
study, the methodology pertaining to estimating the burden
of alcohol dependence was often under-reported or poor. In
addition, some reports captured by the literature searching
were not primary studies but poorly referenced reviews,
many of the original papers from which were either untrace-
able or unobtainable (Trillat, 1980).
In this review, standardization of cost estimates in terms of
converting costs into Euros 2012 and presenting them as a
proportion of GDP per country was performed to make costs
more comparable between studies and across years. Despite
the differences in methodology and uncertainty in cost esti-
mates, it is reassuring to note that after conversion, all
annual direct cost estimates fell within the relatively small
range of 0.04–0.31% of GDP (Table 5). However, the range
obtained for annual indirect costs of 0.001–0.6% of GDP
(Table 6) is significantly larger. This is likely to be due to
greater variation in the indirect cost components included in
each study and differences in methodology.
It was not possible to perform data adjustment to account
for differences in resource utilization as a result of, for
example, changes in standard care procedures for treating
alcohol-dependent patients. Variation in length of stay per
hospitalization per patient in two examples from France (55
days in 1964 versus 11 days in one specialist centre in 2000;
Lereboullet, 1968 and Nalpas et al., 2003) could improbably
be interpreted as meaning that the healthcare resource burden
of alcoholism in France has declined over time. More likely,
the difference is due to a combination of different included
populations and study designs and the fact that for many
years now relapse prevention treatment has been preferential-
ly conducted in an outpatient setting (European Medicines
Agency, 2010).
A number of problems associated with the use of hospital
or patient records in prevalence-based and top-down
approaches to cost estimation mean that the economic burden
of alcohol dependence in Europe has almost certainly been
underestimated in this review. For example, many studies
reporting the direct national costs of alcohol dependence
(Table 5) are likely to have only included costs for health
conditions wholly attributable to alcoholism (such as alco-
holic liver cirrhosis). Health care costs for conditions where
alcoholism is only one of a number of component causes,
such as cancer and cardiovascular disease, may not have
been captured at all. In addition, it has previously been pro-
posed that there may be some stigma associated with disease
category codes with ‘alcoholic’ in the name, which may lead
to under-reporting of these categories in hospital records
(Rehm et al., 2010). Finally, it is the case that only a minor-
ity of patients suffering from alcohol use disorders receive
treatment for their condition in Europe, with one estimate as
low as 8.3% (Alonso et al., 2004).
The relative paucity of studies in the literature addressing
the economic burden of alcohol dependence presents an op-
portunity for new studies to be performed on this potentially
manageable population of individuals. Based on our review
of the available literature, it is clear that some degree of
standardization in methodology and approach would benefit
this important therapeutic area. Prospective studies should
clearly define the alcohol-dependent population they are
investigating in terms of ICD-10 or DSM-IV criteria.
Furthermore, a detailed breakdown of cost components
within broader categories such as ‘drug costs’ and ‘hospital-
ization’ should be provided, as well as greater clarification
of terms such as, ‘alcohol-related health disorders’ and
‘withdrawal syndrome’. Assumptions and data adjustments
should be highlighted in a transparent and reproducible
manner.
In conclusion, despite the shortcomings of the data dis-
cussed above, the economic burden associated with alcohol
dependence is significant and represents a significant propor-
tion of the costs associated with alcohol misuse overall. In
addition, these shortcomings may have led to an underesti-
mation of the impact, and further cost-of-illness studies in
this therapeutic area are urgently needed. The value of such
studies lies in their potential to define the extent of the
adverse economic consequences associated with alcohol de-
pendence, and the projected gains to be made from effective
prevention and treatment. The variable quality of many
studies means that they cannot be used with confidence in
this respect. The development of a reliable evidence base for
understanding the large economic burden associated with
alcohol dependence may have important policy implications
for healthcare systems and society overall.
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